# Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma

> **NCT02173093** · PHASE1,PHASE2 · UNKNOWN · sponsor: **University of Virginia** · enrollment: 40 (estimated)

## Conditions studied

- Disseminated Neuroblastoma
- Recurrent Neuroblastoma

## Interventions

- **BIOLOGICAL:** IL-2
- **BIOLOGICAL:** GD2Bi-aATC
- **BIOLOGICAL:** GM-CSF
- **OTHER:** laboratory evaluations of immune responses

## Key facts

- **NCT ID:** NCT02173093
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02173093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02173093, "Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02173093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*